A systematic review of contemporary phase I trials in patients with lymphoma
Griguolo, G., Zorzi, M.F., Pirosa, M.C., Treglia, G., Bertoni, F., Kuruvilla, J., Zucca, E., Stathis, A.
Published in Critical reviews in oncology/hematology (01.12.2022)
Published in Critical reviews in oncology/hematology (01.12.2022)
Get full text
Journal Article
Primary lymphoma of the female genital tract: a retrospective survey of the International Extranodal Lymphoma Study Group (IELSG35)
Steffanoni, S., Vanazzi, A., Esposito, F., Cabrera, M. E., Akhtar, S. S., Gardella, S., Bairey, O., Pavlovsky, A., Polino, A., Landi, F., Stathis, A., Zucca, E., Pirosa, M. C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY
Østenstad, B., Pirosa, M. C., Schär, S., Brodtkorb, M., Wahlin, B. E., Hernberg, M., Pedersen, M., Stathis, A., Zander, T., Novak, U., Zenz, T., Fischer, N., Krasniqi, F., Hitz, F., Jjohansson, A., Lofgren, D., Meyer, P., Bjørnevik, A. T., Hayoz, S., Scheibe, B., Steiner, L., Dirnhofer, S., Ceriani, L., Zucca, E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
IBRUTINIB TOLERABILITY AND OUTCOME IN PATIENTS WITH HIGH‐RISK CHRONIC LYMPHOCYTIC LEUKEMIA
Condoluci, A., Terzi‐di‐Bergamo, L., Forestieri, G., Moia, R., Deambrogi, C., Deodato, M., Frustaci, A. M., Merli, M., Mattarucchi, R., Autore, F., Fahrni, G., Scarfò, L., Gussetti, D., Bulian, P., Zanatta, A., Spina, V., Faderl, M. R., Bruscaggin, A., Pini, K., Piffaretti, D., Koch, R., Pirosa, M. C., Cittone, M. G., Passweg, J., Cavalli, F., Zucca, E., Gerber, B., Gillessen, S., Stüssi, G., Gattei, V., Ghia, P., Gregor, M., Laurenti, L., Passamonti, F., Tedeschi, A., Gaidano, G., Rossi, D.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA
Spina, V., Pirosa, M. C., Bruscaggin, A., Condoluci, A., Pini, K., Forestieri, G., Zangrilli, I., di Trani, M., Kurlapski, M., Moccia, A., Moia, R., Bulian, P., Annunziata, S., Borsatti, E., Rodari, M., Romanowicz, G., Sacchetti, G. M., Faderl, M., Koch, R., Piffaretti, D., Terzi di Bergamo, L., Stasia, A., Cittone, M., Chauvie, S., Stüssi, G., Gerber, B., Stathis, A., Sommer, S. Gillessen, Cavalli, F., Zucca, E., Gattei, V., Zaucha, J. M., Pinto, A., Gaidano, G., Carlo‐Stella, C., Hohaus, S., Ceriani, L., Rossi, D.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38)
Pirosa, M. C., Orsucci, L., Feugier, P., Tani, M., Ghesquieres, Hervé, Musuraca, G., Baldini, L., Merli, F., De Renzis, B., Gyan, E., Gini, G., Marino, D., Gressin, R., Morschhauser, F., Palombi, F., Cavallo, F., Conconi, A., Le Gouill, S., Tilly, Hervé, Zanni, M., Cabras, M. G., Capochiani, E., Califano, C., Molinari, A. L., Pulsoni, A., Angrilli, F., Cartron, G., Casasnovas, O., Devizzi, L., Haioun, C., Houot, R., Liberati, A. M., Occhini, U., Merli, M., Pietrantuono, G., Re, F., Spina, M., Esposito, F., Bertoni, F., Rossi, D., Ielmini, N., Luminari, S., Cavalli, F., Zucca, E., Stathis, A., Thieblemont, C.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
Pirosa, M. C., Bruscaggin, A., Terzi di Bergamo, L., Salehi, M., Pini, K., Spina, V., Bocchetta, S., Condoluci, A., Forestieri, G., Piffaretti, D., Marques De Almeida, J., Annunziata, S., Bergesio, F., Borsatti, E., Bulian, P., Chauvie, S., Marco, C., Martina, D. T., Bernhard, G., Kurlapski, M., Moccia, A., Moia, R., Rinaldi, A., Rodari, M., Romanowicz, G., Sacchetti, G. M., Stasia, A., Stathis, A., Stüssi, G., Zangrilli, I., Larocca, L. M., Pinto, A., Santoro, A., Cavalli, F., Zucca, E., Gattei, V., Zaucha, J. M., Carlo‐Stella, C., Hohaus, S., Gaidano, G., Ceriani, L., Rossi, D.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Pirosa, M C, Bruscaggin, A, Terzi di Bergamo, L, Salehi, M, Spina, V, Pini, K, Bocchetta, S, Giordano, C, estieri, G, Condoluci, A, Piffaretti, D, De Almeida, J Marques, Galimberti, G A, Annunziata, S, Bergesio, F, Boldorini, R, Borsatti, E, Bulian, P, Chauvie, S, Cuzzocrea, M, di Trani, M, Cristaldi, V, Gerber, B, Jauk, F, Kurlapski, M, Larocca, L M, Moccia, A, Moia, R, Rinaldi, A, Rodari, M, Romanowicz, G, Sacchetti, G M, Stathis, A, Stüssi, G, Zangrilli, I, Pinto, A, Mazzucchelli, L, Gattei, V, Zaucha, J M, Hohaus, S, Santoro, A, Carlo-Stella, C, Gaidano, G, Cavalli, F, Zucca, E, Ceriani, L, Rossi, D
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)
Moccia, Alden Alberto, Schär, Sämi, Hayoz, Stefanie, Pirosa, Maria Cristina, Taverna, Christian, Novak, Urban, Kimby, Eva, Ghielmini, Michele, Zucca, Emanuele
Published in British journal of haematology (01.03.2021)
Published in British journal of haematology (01.03.2021)
Get full text
Journal Article